|
|
|
|
|
|
Trinity Bio ADR (TRIB)
|
|
5.91 +0.03 (+0.51%)
|
6/23/2017 12:49pm
|
|
Open:
|
5.87
|
Pre. Close:
|
5.88
|
|
High:
|
5.98
|
Low:
|
5.85
|
|
Volume:
|
9,125
|
Market Cap:
|
130.62M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
6.06 - 6.15
|
6.15 - 6.24
|
|
Low:
|
5.65 - 5.72
|
5.72 - 5.79
|
|
Close:
|
5.77 - 5.88
|
5.88 - 6
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-23 12:16:31 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 7.24 One year: 8.46
|
|
Support:
|
Support1: 5.61 Support2: 5.24
|
|
Resistance:
|
Resistance1:
6.20 Resistance2: 7.24
|
|
Pivot:
|
5.88 
|
|
Moving Averages:
|
MA(5): 5.89 MA(20): 5.79
MA(100): 5.80 MA(250): 7.96
|
|
MACD:
|
MACD(12,26):
0.10 Signal(12,26,9): 0.10
|
|
%K %D:
|
%K(14,3): 61.96 %D(3): 65.58
|
|
RSI:
|
RSI(14): 55.41
|
|
52-Week:
|
High: 13.68
Low: 5.20 Change(%): -48.4
|
|
Average Vol(K):
|
3-Month: 52
10-Days 64
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.TRIB has closed above bottom band by 48.1%. Bollinger Bands are 40.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to TRIB's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
Fri, 11 May 2007 06:56:15 GMT
News Trinity Biotech PLC ADRTRIB
Tue, 07 Jul 2009 13:44:26 GMT
5.91
Fri, 23 Jun 2017 00:33:45 GMT
Analysts See $0.03 EPS for Trinity Biotech plc (ADR) (TRIB)
Thu, 27 Apr 2017 23:00:09 GMT
Trinity Biotech's (TRIB) CEO Ronan O'Caoimh on Q1 2017 Results - Earnings Call ...
Sat, 17 Jun 2017 01:09:40 GMT
Trinity Biotech plc (ADR) (TRIB) Analysts See $0.03 EPS
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
